[Experimental-clinical study of combined use of antibiotics and prodigiozan].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use / Q000633:toxicity*; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D004357:Drug Synergism; D004361:Drug Tolerance; D015643:Erythromycin Ethylsuccinate / Q000633:toxicity; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000187:drug effects; D007964:Leukocytosis / Q000139:chemically induced; D051379:Mice; D009869:Oophoritis / Q000188:drug therapy; D010587:Phagocytosis / Q000187:drug effects; D011113:Polymyxins / Q000633:toxicity*; D011135:Polysaccharides, Bacterial / Q000494:pharmacology* / Q000627:therapeutic use; D012488:Salpingitis / Q000188:drug therapy; D012706:Serratia marcescens; D013492:Suppuration / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D011113:Polymyxins; D011135:Polysaccharides, Bacterial; D015643:Erythromycin Ethylsuccinate
Eksperimental'no-klinicheskoe issledovanie kombinirovannogo primeneniia antibiotikov i prodigiozana.